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Summary
A large number of class I-like genes are located distal to the K and D regions of the murine
major histocompatibility complex (MHC) within the Q and TL region. The function of the
molecules encoded within this region is obscure since unlike conventional MHC gene products,
these molecules have not been reported to present processed environmental antigens to T cells.
In the present report, we demonstrate that a peptide corresponding to processed influenza virus
hemagglutinin can be recognized by CD8+ T cell receptor a//3-positive cytotoxic T lymphocytes
(CTL) in association with a MHC class I-like product encoded within the TL region. Thus,
nonconventional class I MHC molecules can bind and present processed environmental antigens,
and TCR-a/(3 CTL directed to such peptide MHC complexes are represented in the mature
T cell pool. Our data imply that Q/TL region products may be charged by peptides generated
through an antigen processing and presentation pathway distinct from the pathway used by
conventional MHC molecules and not normally available to environmental antigens.
M
urine H-2 region-encoded class I MHC molecules are
cell surface glycoproteins associated noncovalently with
(32-microglobulin (02m). 1 These highly polymorphic mole-
cules are expressed ubiquitously, and function both as trans-
plantation antigens and as restriction elements for CD8+ T
lymphocytes (1, 2). Nonconventional class I MHC molecules
of the Q and TL regions are structurally similar to H-2 class
I MHC molecules, but differ in tissue expression and level
of polymorphism (3, 4). With few notable exceptions (5,
6), these molecules have not been reported to serve as restric-
tion elements for foreign antigen-specific T lymphocytes. Re-
cent work has suggested a possible role for these molecules
as restriction elements in recognition ofphylogenetically con-
served self-antigens by TCR-y/S+ T lymphocytes (7-9). In
this report, we have identified a site on influenza virus hemag-
glutinin (HA) definable as a short synthetic peptide that is
recognized by CD8+, TCRa/a+ T lymphocytes restricted
by a TL region-encoded class I MHC molecule. This finding
implies that nonconventional classI MHC molecules can bind
processed foreign antigen fragments and have the potential
to present environmental antigens to conventional TCR
ac//3+ T cells.
1 Abbreviations used in this paper . i32m, /32-microglobulin; HA, hemag-
glutinin.
Materials and Methods
Mice. BALB/cByJ (H-2d), CBA/J (H-21), and C57BL/6
(H-26) mice were purchased from The Jackson Laboratory (Bar
Harbor, ME). C3H/HeN, A.SW, B10.A, B10.BR, ATL, A/J, and
B10.M mice were purchased from theJewish Hospital ofSt. Louis
Animal Facility (St. Louis, MO). B6.AC1, B6Tla', A.CA, and
B6.AC3 mice were bred and maintained in the Laboratory of Im-
munology, Wadsworth Center for Laboratories and Research (Al-
bany, NY).
Cell Lines.
￿
The P815 (H-2d) mastocytoma cell line and the
S49.35 (H-2d) lymphoma were maintained in DME (Gibco
Laboratories, Grand Island, NY) and supplemented with 10%
(vol/vol) FCS and 1% (wt/vol) glutamine. L929 (H-2') fibroblasts
were grown in DME and 10% FCS. The E14 (H-26) thymoma,
the 02m-deficient line R1.E (H-2k), and its parental line R1.1 were
maintained in RPMI (Gibco Laboratories), 10% FCS, and 1% gluta-
mine. The S49.35, RLE, and R1.1 cell lines were the kind gift
of Dr. Ted Hansen (Washington University School of Medicine,
St. Louis, MO).
Antibodies.
￿
Affinity-purified antibody H57-579 (10) (pan-reactive
anti TCRa//3 antibody) was obtained from Dr.Jeffrey Lake (Jewish
Hospital, St. Louis, MO). The 3A10 anti TCR--y/S antibody (11)
was obtained as a hybridoma supernatant from Dr. Osami Kanagawa
(Washington University School ofMedicine). Anti-CD8 (53.6.2)
and anti-CD4 (GK1.5) antibodies were used as hybridoma super-
natants.
Peptides.
￿
Nested peptides corresponding to residues 170-199 of
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a rapid amino acid multiple peptide synthesizer system (DuPont
Co., Wilmington, DE).
Assays for Cell-mediated Cytotoxicity. Standard "Cr release
assays and theresultantdata were analyzed as previously described
(12, 13). Cytolysis oflymphoblast targetsby HA 173-190-reactive
cytolytic lymphocytes was measured by release of radiolabeled
(111'l]-lUdR) DNA fragments from detergent permeabilized
nuclei as described(14).Briefly, splenocytes from theindicated strains
of mice were cultured for 48 h in the presence of 2.0 pg/ml Con
A. Viable blasts were washed, and labeled 1.5 h at 37°C with 25
ACi [1251]-IUdR per 106 lymphoblasts. 10"target cells, C57BL/6-
derived effector T lymphocytes at an E/T ratio of 5:1, and HA
173-190peptide at finalconcentrations from 10 to 0.1 Ag/ml (results
using 10 pg/ml only are shown) were added to 96-well round-
bottomed microtiter plates. Plates were centrifuged 2 min at 50
g and incubated for 3 h at 37°C in 10% C02. 30 pl of 4% Triton
X-100 was added to each well and mixed with a 12-channel pi-
pette. The plates were centrifuged for 5 min at 850g, and 0.1 ml
supernatant was removed from each well and counted. The per-
cent specific lysis was determined as describedpreviously (12, 13).
SE were <5% of the mean values in all cases and are omitted.
Peptide-reactive T Lymphocytes.
￿
HA 173-190-reactive CTL were
established by amodification ofapreviously describedmethod (15).
Briefly, 7 x 107 naive splenocytes were cultured in the presence
of 10 Ag/ml HA 173-190 (total volume, 10 ml) in upright 25-cm'
tissue culture flasks. Bulk cultures were restimulated after 10 dwith
10 pg/mlHA 173-190peptide, exogenous growth factors, and ir-
radiated (2,000 rad) syngeneic splenocytes in 12-well tissue culture
plates.
Flow Cytometry Analysis. C57BL/6-derived HA 173-190-
reactive T lymphocytes were labeled with normal hamster IgG as
a control or with the pan-reactive antiTCR-cx/R mAb H57-597
(10) or the pan-reactive antiTCR-y/S mAb 3A10 (11), followed
by staining with FITC-conjugated goat anti-hamster IgG. Flow
cytometryanalysis wasperformed on a FRCS®440 flow cytometer
(Becton Dickinson & Co., Mountain View, CA).
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lymphocytes. HA 173-190-reactive cytolytic lymphocytes of C57BL/6J (0, ") or CBA/J
cell line (open circle) that lacks H-2K, D/L classI MHC molecules of the H-2d haplotype,
and nonconventional class I molecules.
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Table 1 .
￿
The Restriction Element for HA 173-190-reactive
T Lymphocytes Maps to the TL Region
Percent
specific lysis`
HA 173-190
MHC haplotype
￿
peptide
" Values are themean percent specific release from triplicate samples. SE
were <5% of mean values and are omitted. The E/T ratio is 5:1.
# Lyphoblasts from the indicated mousestrains were labeledwith [12511_
IUdR, sensitized with peptide, and used as targets in a 3-h [1251]-IUdR
release assay as described in Materials and Methods.
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Figure 1.
￿
Recognition of target cells by HA 173-190-
reactive cytolytic lymphocytes. HA 173-190 peptide-
specific cytolytic lymphocytes from C57BL/6J (A) or
CBA/J (B) mice were derived by in vitro stimulation of
naive splenocyte precursors with peptide and tested for
reactivity on P815 (H-2d; "), L929 (H-2k; "), or E14
(H-26; 0) targets treated with theindicated HA 173-190
peptideconcentrations. Lysis of uninfected andinfluenza
A/JAPAN/57-infectedP815 target cells by HA 173-90-
reactive cytolytic lymphocyte (A, ") or by a Kd-
restricted clone 11-1 (0, +) directed to the im-
munodominant HA 202-221 site (16, 17) expressed on
influenza-infected cells is included. (C) HA 173-190-
reactive Tcellsrecognizing peptide-treated target cellsex-
pressing a2m. HA 173-190-reactive cytolytic cells of
C57BL/6J (O, ") or CBA/J(E], N) origin were tested
for lytic activity on the 02m- R1.E line (open symbols)
and its /32m* (H-2khaplotype) parental line R1.1 (filled
symbols). Lysis by a Kk-restricted HA 252-271-reactive
CTL line (18) of the02m- (A) andtheS2m' (") target
cells treated with theindicated concentrations ofthe HA
252-271 peptide is included. (D) Expression of noncon-
ventional class I MHCmoleculesis sufficient to sensitize
targets for recognition by HA 173-190-reactive cytolytic
(0, 0) originswere tested for lytic activity on the549.35
and on the P815 target cells that express both conventional
A TLrencoded Major Histocompatibility Complex Molecule Presents Antigen
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Target cell#
strain K D/L Q TL - +
1 BALB/c d d d d 14 92
C3H/HeN k k k k 11 95
A.SW s s s s 6 70
B10.A k d a a 25 67
B10.BR k k k a 14 79
A.TL s d d d 9 62
A/J k d a a 21 58
B10.M f f f f 18 27
2 C57BL/6 b b b b 7 68
B6 .AC1 f f b b 6 57
B6 .Tla' b b b a 7 80
A.CA f f f f 9 18
B6 .AC3 b b b f 7 19Results
MHC-unrestricted Recognition ofan InfluenzaHemagglutinin
Site As part of an analysis ofclass I MHC-restricted T cell
responses directed to specific sites ofthe influenza A/JAPAN/
57 virus HA, we screened a panel of synthetic peptides
representing selected regions of the HA molecule as immuno-
gens to induce primary HA-specific cytolytic lymphocyte re-
sponses in vitro (15) . One peptide, HA 173-190, stimulated
an in vitro primary CTL response from murine splenocytes
of several distinct haplotypes (Fig. 1). HA 173-190-specific
cytolytic lymphocytes from either C57BL/6 (H-2b) (Fig. 1
A), CBA(H-2k) (Fig. 1 B), or BALB/c (H-2d) mice (data not
shown) recognized peptide-treated target cells of H-2d (P815
mastocytoma), H-2k (1,929 fibroblast), and H-2b (ELA lym-
phoma) haplotype origin with comparable efficiency. Rec-
ognition oftarget cells was peptide specific as target cells treated
with synthetic peptides corresponding to other sites on the
influenza HA were not lysed (data not shown). Target cells
derived from five independent MHC haplotypes were each
lysed in a peptide-specific manner (see Table 1). Importantly,
while these HA 173-190-specific cytolytic lymphocytes rec-
ognized peptide-treated target cells, the cytolytic lympho-
cytes did not recognize cells expressing the A/JAPAN/57
HA as a result of infection with influenza virus (Fig. 1, A
and B). Influenza-infected cells were recognized by H-2Kd-
restricted CD8+ CTL directed to an immunodominant site,
HA 202-221(16, 17), in close proximity to the HA 173-190
site on the HA molecule (Fig. 1, A and B).
Role ofSerologically DefinedMHC Molecules in Target Cell
Recognition. To determine the role of MHC molecules in
this peptide-specific, MHC-unrestricted recognition, we ex-
amined the requirement for class I MHC expression on target
cells by testing the ability of HA 173-190-specific CTL to
recognize the 02m-deficient cell line RLE. This cell is of
H-2k haplotype origin but lacks detectable surface class I
MHC molecules. The 02m- R1.E line was not recognized
by HA 173-190-specific CTL nor by an H-2Kk-restricted
CTL line (specific for HA residues 252-271) in the presence
of the appropriate HA 252-271 peptide (18). The corre-
sponding 02m
+ class I MHC expressing parental R1.1 line
was recognized by both CTL populations (Fig. 1 C). The
R1.E targets were, however, susceptible to lectin-dependent
lysis by activated CTL populations (data not shown), indi-
cating that the failure of R1.E to be lysed in the presence
of peptide resulted from a lack oftarget cell recognition rather
than resistance of R1.E to lysis.
To assess the role of serologically defined H-2K, D, or L
locus class I molecules in the recognition ofthe HA 173-190
site, we tested the ability of these CTL to recognize the
H-2d lymphoma 549.35, which expresses nonconventional
class I MHC antigens but not H-2K or D/L molecules (19).
HA 173-190-specific CTL of both C57BL/6 and CBA/J
origin lysed HA 173-190-sensitized 549.35 and P815 cells (Fig.
1 D). The H-2Kd-restricted CTL clone 11-1 (16, 17) lysed
P815 but not S49.35 targets in the presence of the appro-
priate peptide (i.e., HA 202-221), consistent with a lack of
Kd expression on the surface of the 549.35 cells (data not
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shown) . Our findings with the R1.E and the S49.35 line im-
plied that the cytolytic lymphocytes directed to HA 173-190
were restricted to a fl2m-dependent nonpolymorphic gene
product, presumably a nonconventional class I MHC mole-
cule mapping telomeric to the H-2 D/L region.
Genetic Mapping of the Restriction Element to the TL Re-
gion. In an attempt to more precisely map the restricting
element for the HA 173-190 response to the Q or TL regions,
we examined peptide-dependent recognition oflymphoblast
target cells from mouse strains with deletions and/or sero-
logical polymorphisms in the Q or TL regions. Target cells
ofmost Q/TL haplotypes were lysed in a peptide-dependent
fashion with comparable efficiency (Table 1, Exp. 1). In con-
trast, target cells o£ the TV haplotype (B10.M strain) were
not (Table 1, Exp. 1). To further link unresponsiveness to
the TV haplotype and to exclude the possibility of recogni-
tion of a Q region product encoded in a region deleted from
the B10.M genome (20), we analyzed the recognition oflym-
phoblast targets from recombinant congenic mouse strains.
Target cells from B6 .AC1 (Qb TLb) and B6Xla' (Qb TL')
mice, but not B6.AC3 (Qb TV), were recognized in a
peptide-dependent fashion by HA 173-190-specific CTL.
Table 2.
￿
Recognition of a Nested Series of Peptides
6y HA 173-190-reactive T Cells
Synthetic peptides
173 176 180 184 188 192 198
Percent specific
S1CR release"
HA 173-190-
reactive T cells#
CBA/J C57BL/6
" As in Table 1.
t Indicates strain of origin of HA 173-199-reactive T cells.
S Indicates sequence of the synthetic peptide used to treatthe target cells.
The amino acid sequence corresponding to A/JAP/305/57 HA residue
173-199 is given for reference.
VAKGSYNNTSGEQMLIIWGVHHPIDET
VAKGSYNNTSGE
Q
MLIIW 68 73
VAKGSYNNTSGE 0 ND
KGSYNNTSGEQM 0 ND
SYNNTSGEQMLI 0 7
NNTSGEQMLIIW 76 70
TSGE MLIIWGV 70 73
GEQMLIIWGVHH 77 76
QMLIIWGVHHPI 71 72
MLIIWGVHHPID 52 79
LIIWGVHHPIDE 1 7
IIWGVHHPIDET 0 7
No peptide 0 9Thus, HA 173-190 reactivity maps to a restriction element
shared by strains of the TL a, b, d, k, or s haplotypes, but
absent from TV mice.
Although these data definitively map the restriction ele-
ment distal to the Q region, the distal border of the TL re-
gion is not precisely defined and thus we cannot exclude the
possibility that the restriction element maps telomeric to the
TL region. This possibility seems less likely, given the highly
conserved nature of the relatively few class Mike molecules
that have been mapped to this telomeric region.
TLrestricted Recognition Is Residue Specific.
￿
TL region-
linked recognition by HA 173-190-specific T cells required
a critical core of residues within the HA 173-190 site. Table
2 illustrates an analysis with a set of nested 12 mer peptides
spanning residues 173-199. Peptides containing the hydro-
phobic residues 186-190 (MLIIW) were recognized by HA
173-190-specific T cells from both C57BL/6 and CBA/Jmice.
This result suggests that a single common epitope may be
recognizedin association with the TL region product by HA
173-190-reactive T cells from several distinct haplotypes.
Cell SurfacePhenotypeofTLrestricted TLymphocytes.
￿
The
phenotype of HA 173-190-specific cytolytic cells from BALB/c
x C57BL/6 Fl, CBA/J, and C57BL/6 mice, as determined
by flow cytometry, was predominantly (>75%) Thy-1+,
CD3+, CD8+ (data not shown). After primary stimulation
of splenocyte precursors, a subset of Thy-1+, CD3+, CD4+
cells initially present was lost upon subsequent stimulation
of the cells with HA 173-190 peptide, and the resulting popu-
Relative Fluorescence Intensity
lation was exclusively CD8+ . Bulk lines of HA 173-190-
specific CD8+ cytolytic cells also stained with a mAb
specific for a framework determinant on TCR-oi//3 (10) in-
dicating that these TL region-restricted CD8+ CTL used
TCRa/a (Fig. 2 A). The HA 173-190-reactive population
did not stain with a 7/S framework reagent (11) . Cytolysis
of HA 173-190-sensitized targets was blocked by anti-CD8
antibody but not by anti-CD4 antibody (Fig. 2 B), suggesting
a functional interaction between the CD8 molecules and the
TL region-encoded class I MHC molecules.
Discussion
The function of Q and TL region MHC molecules is
unclear. The predicted structures of Q and TL molecules
derived from examination of a number of cloned genes sug-
gests these molecules should fold into structures capable of
forming a peptide binding groove (21). In this report, we
demonstrate that CD8 + , TCR-a//3+ CTL from several in-
dependent haplotypes can recognize a site on a viral antigen
in association with a TL region-encoded classI MHC product.
These results along with structural evidence of sequence ho-
mology with conventional class I MHC molecules support
the concept that Q and TL region molecules are capable of
binding processed antigen fragments (21). The demonstra-
tion of peptide sequence-dependent sensitization of target
cells by the HA peptide as well as the demonstration of a
nonresponder haplotype (i.e., TV) also suggest that there is
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Figure 2.
￿
TCR chains used by HA 173-190-reactive T lymphocytes. (A) C57BL/6-derived HA 173-190-reactive T lymphocytes were labeled with
normal hamster IgG as a control or with the pan-reactive antiTCR-cx/(3 mAb H57-597 (10) or the pan-reactive antiTCR-y/S mAb 3A10 (11), followed
by staining with FITC-conjugated goat anti-hamster IgG. Flow cytometry analysis was performed on a FACS® 440 flow cytometer (Becton Dickinson
& Co.). (B) CBA/J-derived HA 173-190-reactive lymphocytes were incubated with anti-CD8 (/) or anti-CD4 (0) antibody-containing supernatants
at the indicated dilutions for 30 min at 37°C before the addition of P815 targets and HA 173-190 at a final concentration of 10 Fcg/ml. Percent specific
lysis for a 6-h s'Cr release assay was calculated as for Fig. 1.
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tide and critical contact residues in a TL region-encoded MHC
molecule. Since processed antigen can selectively bind to TL
region molecules and since there are reactive CD8+ T cells
in mice of several distinct haplotypes, the inability of HA
173-190-specific T cells to recognize virus-infected cells (Fig.
1, A and B) suggests that complexes of processed antigen
and TL region molecules may not be formed or formed
efficiently during viral infection.
For an antigen to be recognized by T cells, processed an-
tigen fragments must have the capacity to bind to MHC mol-
ecules, and T cellscapable of stimulation by the relevant pep-
tide MHC complex must be resident in the responding
individual. The finding that the HA 173-190 peptide can
stimulate CD8+ CTL that recognize HA 173-190-treated
cells in a TLrestricted haplotype-dependent fashion suggests
that in several different mouse strains potentially reactive T
cells are present and TL product-peptide complexes can be
formed. The inability of HA 173-190-specific CD8+ CTL
to recognize virus-infected cells (Fig. 1, A and B) and our
failure to detect HA 173-190-reactive TLrestricted CD8+
CTL during influenza infection (22) implies that complexes
between processed HA and TL region molecules may not
be efficiently formed (or formed at all) during influenza in-
fection of target cells in vitro or APC in vivo.
It is possible that the HA 173-190 site is not generated
during HA processing in influenza-infected cells because of
inaccessibility of this region of the molecule to proteolytic
cleavage. This remains a formal possibility but seems unlikely
since HA 173-190 is in close proximity to an immuno-
dominant site (HA 202-221), which is readily generated during
infection with influenza virus (17, 22). Furthermore, we have
expressed the preprocessed HA 173-190 site into target cells
in the form of a minigene (18, 23) encoding only HA residues
173-190. Target cells expressing this minigene product are
not recognized by the HA 173-190-reactive CD8+ CTL
(G. N. Milligan, unpublished observations). It is also for-
mally possible that the residues in HA 173-190 site critical
for TL binding are selectively destroyed during processing
of HA in the infected cell. While we cannot exclude this
possibility in the case of HA 173-190 recognition in associa-
tion with TL, it seemsunlikely that such a mechanism could
account for the general failure of processed antigen from the
large number of viruses studied to date to be recognized in
association with nonconventional class I MHC antigens.
One attractive explanation for the failure of influenza and
other environmental antigens to stimulate CD8+ CTL re-
stricted to nonconventional class I MHC products is that non-
conventional class I molecules are charged by antigen frag-
ments processed via a pathway distinct from the processing
pathway used in the presentation of environmental antigens
in association with conventional class I MHC molecules. Thus,
as first suggested from the analysis of CTL recognition of
the maternally transmitted antigen(s), processed environmental
antigens like the influenza HA may not be available to charge
TLencoded class I molecules. These Q/TL products may
only be charged by a unique subset of antigen fragments
originating from selfproteins within the cell. While this hy-
pothesis is intriguing, it is equally likely that the kinetics
of synthesis and turnover of the critical Q/TL molecules that
serve as restricting elements, their steady state level of ex-
pression, or their rate of transit through particular intracel-
lular compartments may limit their ability to bind processed
viral antigens. Accordingly, efficient presentation of foreign
antigenic peptides in association with Q/TL molecules may
not occur when the antigen is transiently expressed in the
cell, e.g., during viral infection. Furthermore, the tissue
specificity and relativelylow levelof expression ofmost non-
conventional class I antigens probably also limits their ca-
pacity to serve as restricting elements in the presentation of
viral antigens to CD8+ CTL. Experiments are currently un-
derway to assess the effect of the magnitude and duration
of viral gene expression on the recognition of the HA by
TL restricted CD8+ CTL.
In conclusion, we have demonstrated that a nonconven-
tional MHC class I locus allele mapping to the TL region
presents an influenza HA fragment to CD8+ CTL. Thus,
TL region products appear to have the capacity to present
an environmental antigen to CD8+ CTL but fail to do so
during viral infection. The mechanistic basis for the defect
in the presentation of environmental pathogens in associa-
tion with nonconventional class I gene products remains to
be elucidated. Understanding the nature of this presentation
defect should provide additional insight into the cell biology
of antigen processing.
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